Literature DB >> 134123

Leukocyte migration inhibitory factor (LMIF) production in unidirectional mixed lymphocyte cultures.

A J Górski, B Dupont, J A Hansen, R A Good.   

Abstract

Puromycin treatment of lymphocytes was used to develop a one-way test for leukocyte migration inhibitory factor (LMIF) production in the mixed lymphocyte culture (MLC) reaction. Lymphocytes incubated with this protein synthesis inhibitor induced a vigorous mediator production by nontreated allogeneic cells, being themselves unable to respond to stimulator cells. When puromycin-treated cells were stimulated with the mitogens PHA, ConA, or PWM, overall protein and DNA synthesis were significantly decreased with concomitant abolishment of LMIF production. Viability of stimulator lymphocytes was found to be essential for generation of the mediator in MLC reaction.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 134123

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  2 in total

1.  Cellular co-operation in the production of human leucocyte inhibitory factor by lymphocyte subpopulations stimulated with antigens and allogeneic cells.

Authors:  L Räsänen
Journal:  Immunology       Date:  1979-08       Impact factor: 7.397

2.  Maternal cell-mediated immunity in normal and pre-eclamptic pregnancy.

Authors:  I L Sargent; C W Redman; G M Stirrat
Journal:  Clin Exp Immunol       Date:  1982-12       Impact factor: 4.330

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.